Inhibitors of PI3 kinase and/or mTOR
US8362241B2 · kind B2 · utility
10Cited by
1References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 27, 2010 |
| Grant date | Jan 29, 2013 |
| Priority date | — |
| Expiry date | Oct 20, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt thereof;methods of treating diseases or conditions, such as cancer, using the compounds; and
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.